Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,401
archived clinical trials in
Alzheimer Disease

Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  1/23/2018
US341
mi
from
Pittsburgh, PA
Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 1/23/2018
US341
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  1/23/2018
US325
mi
from
Reading, PA
Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 1/23/2018
US325
mi
from
Reading, PA
Click here to add this to my saved trials
Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  1/23/2018
US319
mi
from
Port Royal, SC
Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 1/23/2018
US319
mi
from
Port Royal, SC
Click here to add this to my saved trials
Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  1/23/2018
US356
mi
from
Cordova, TN
Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 1/23/2018
US356
mi
from
Cordova, TN
Click here to add this to my saved trials
Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  1/23/2018
US343
mi
from
Fort Worth, TX
Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 1/23/2018
US343
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  1/23/2018
US354
mi
from
Houston, TX
Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 1/23/2018
US354
mi
from
Houston, TX
Click here to add this to my saved trials
Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  1/23/2018
AR303
mi
from
Banfield,
Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 1/23/2018
AR303
mi
from
Banfield,
Click here to add this to my saved trials
Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  1/23/2018
US310
mi
from
Saint Paul, MN
Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 1/23/2018
US310
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  1/23/2018
US339
mi
from
Manchester, NJ
Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 1/23/2018
US339
mi
from
Manchester, NJ
Click here to add this to my saved trials
Repetitive Transcranial Magnetic Stimulation for Apathy in Alzheimer's Dementia
Repetitive Transcranial Magnetic Stimulation for Apathy in Alzheimer's Dementia
Status: Enrolling
Updated:  1/23/2018
Central Arkansas Veterans Healthcare System
mi
from
Little Rock, AR
Repetitive Transcranial Magnetic Stimulation for Apathy in Alzheimer's Dementia
Repetitive Transcranial Magnetic Stimulation for Apathy in Alzheimer's Dementia
Status: Enrolling
Updated: 1/23/2018
Central Arkansas Veterans Healthcare System
mi
from
Little Rock, AR
Click here to add this to my saved trials
Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: Health Outcome
Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: A Randomized Controlled Trial: Further Study, Health Outcome
Status: Enrolling
Updated:  1/23/2018
New York University School of Medicine
mi
from
New York, NY
Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: Health Outcome
Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: A Randomized Controlled Trial: Further Study, Health Outcome
Status: Enrolling
Updated: 1/23/2018
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's Disease
Efficacy of Donepezil in Normalizing Brain Activation Patterns in People Genetically at Risk for Alzheimer's Disease
Status: Enrolling
Updated:  2/1/2018
Vanderbilt University Medical Center
mi
from
Nashville, TN
Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's Disease
Efficacy of Donepezil in Normalizing Brain Activation Patterns in People Genetically at Risk for Alzheimer's Disease
Status: Enrolling
Updated: 2/1/2018
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Statins in Cerebral Blood Flow and Neuronal Activity--A Pilot Study
The Effect of Statins on Cerebral Blood Flow and Neural Activity—A Non-Randomized Pilot Study
Status: Enrolling
Updated:  2/15/2018
Cedars-Sinai Medical Center - S. Mark Taper Foundation Imaging Center
mi
from
Los Angeles, CA
Statins in Cerebral Blood Flow and Neuronal Activity--A Pilot Study
The Effect of Statins on Cerebral Blood Flow and Neural Activity—A Non-Randomized Pilot Study
Status: Enrolling
Updated: 2/15/2018
Cedars-Sinai Medical Center - S. Mark Taper Foundation Imaging Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Seizure Activity in Alzheimer's Disease
Seizure-like Hippocampal Activity in Alzheimer's Disease Neurodegeneration
Status: Enrolling
Updated:  2/22/2018
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Seizure Activity in Alzheimer's Disease
Seizure-like Hippocampal Activity in Alzheimer's Disease Neurodegeneration
Status: Enrolling
Updated: 2/22/2018
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Behavioral Expressions in Alzheimer's Disease
An Analgesic Trial to Reduce Pain and Behavior Disruptions in Nursing Home Residents With Alzheimer's Disease
Status: Enrolling
Updated:  3/1/2018
Oak Hammock Continuing Care Retirement Faculty
mi
from
Gainesville, FL
Behavioral Expressions in Alzheimer's Disease
An Analgesic Trial to Reduce Pain and Behavior Disruptions in Nursing Home Residents With Alzheimer's Disease
Status: Enrolling
Updated: 3/1/2018
Oak Hammock Continuing Care Retirement Faculty
mi
from
Gainesville, FL
Click here to add this to my saved trials
Sleep, Aging and Risk for Alzheimer's Disease
Sleep, Aging and Risk for Alzheimer's Disease (SARA) Study
Status: Enrolling
Updated:  3/6/2018
NYU Sleep Disorders Center
mi
from
New York, NY
Sleep, Aging and Risk for Alzheimer's Disease
Sleep, Aging and Risk for Alzheimer's Disease (SARA) Study
Status: Enrolling
Updated: 3/6/2018
NYU Sleep Disorders Center
mi
from
New York, NY
Click here to add this to my saved trials
Sleep, Aging and Risk for Alzheimer's Disease
Sleep, Aging and Risk for Alzheimer's Disease (SARA) Study
Status: Enrolling
Updated:  3/6/2018
NYU Center for Brain Health
mi
from
New York, NY
Sleep, Aging and Risk for Alzheimer's Disease
Sleep, Aging and Risk for Alzheimer's Disease (SARA) Study
Status: Enrolling
Updated: 3/6/2018
NYU Center for Brain Health
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Advanced Memory Research Institute of NJ PC
mi
from
Toms River, NJ
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Advanced Memory Research Institute of NJ PC
mi
from
Toms River, NJ
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Albuquerque Neuroscience Inc.
mi
from
Albuquerque, NM
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Albuquerque Neuroscience Inc.
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Alexian Brothers Neurosciences Institute
mi
from
Elk Grove, IL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Alexian Brothers Neurosciences Institute
mi
from
Elk Grove, IL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Alzheimer's Research and Treatment Center
mi
from
Lake Worth, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Alzheimer's Research and Treatment Center
mi
from
Lake Worth, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Anderson Clinical Research
mi
from
Redlands, CA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Anderson Clinical Research
mi
from
Redlands, CA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
ATP Clinical Research, Inc.
mi
from
Costa Mesa, CA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
ATP Clinical Research, Inc.
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Axiom Clinical Research of Florida
mi
from
Tampa, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Axiom Clinical Research of Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Bradenton Research Center
mi
from
Bradenton, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Bradenton Research Center
mi
from
Bradenton, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Brain Matters Research
mi
from
Delray Beach, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Brain Matters Research
mi
from
Delray Beach, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
CBH Health LLC
mi
from
Rockville, MD
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
CBH Health LLC
mi
from
Rockville, MD
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Clinical Neuroscience Solutions, Inc (CNS Healthcare)
mi
from
Memphis, TN
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Clinical Neuroscience Solutions, Inc (CNS Healthcare)
mi
from
Memphis, TN
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Clinical Trials of America, Inc
mi
from
Winston-Salem, NC
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Clinical Trials of America, Inc
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Coastal Connecticut Research, LLC
mi
from
New London, CT
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Coastal Connecticut Research, LLC
mi
from
New London, CT
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Collaborative Neuroscience Network, Inc.
mi
from
Long Beach, CA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Collaborative Neuroscience Network, Inc.
mi
from
Long Beach, CA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Columbia University Taub Institute
mi
from
New York, NY
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Columbia University Taub Institute
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Compass Research LLC
mi
from
Orlando, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Compass Research LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Feldman, Robert MD
mi
from
Laguna Hills, CA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Feldman, Robert MD
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
FutureSearch Trials of Dallas, LP
mi
from
Dallas, TX
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
FutureSearch Trials of Dallas, LP
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Independent Psychiatric Consultants
mi
from
Waukesha, WI
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Independent Psychiatric Consultants
mi
from
Waukesha, WI
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
JEM Research, LLC
mi
from
Atlantis, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
JEM Research, LLC
mi
from
Atlantis, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
MD Clinical
mi
from
Hallandale Beach, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
MD Clinical
mi
from
Hallandale Beach, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
MedicalPsych Care, PLLC
mi
from
Elmsford, NY
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
MedicalPsych Care, PLLC
mi
from
Elmsford, NY
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Memory Enhancement Centers of America, Inc
mi
from
Eatontown, NJ
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Memory Enhancement Centers of America, Inc
mi
from
Eatontown, NJ
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Meridien Research
mi
from
Brooksville, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Meridien Research
mi
from
Brooksville, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Mile High Research Center
mi
from
Denver, CO
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Mile High Research Center
mi
from
Denver, CO
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Millennium Psychiatric Associates, LLC
mi
from
Creve Coeur, MO
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Millennium Psychiatric Associates, LLC
mi
from
Creve Coeur, MO
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Neuro-Therapeutics, Inc.
mi
from
Pasadena, CA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Neuro-Therapeutics, Inc.
mi
from
Pasadena, CA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Neurobehavorial Clinical Research
mi
from
Canton, OH
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Neurobehavorial Clinical Research
mi
from
Canton, OH
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Neurological Associates of Albany, P. C.
mi
from
Albany, NY
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Neurological Associates of Albany, P. C.
mi
from
Albany, NY
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Neurological Research Center - Hattiesburg Clinic
mi
from
Hattiesburg, MS
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Neurological Research Center - Hattiesburg Clinic
mi
from
Hattiesburg, MS
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Neurological Research Institute
mi
from
Santa Monica, CA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Neurological Research Institute
mi
from
Santa Monica, CA
Click here to add this to my saved trials